The role of (18)F-FDG-PET/CT in characterizing depth of response in high risk smoldering multiple myeloma patients treated with carfilzomib, lenalidomide, and dexamethasone (KRd) Meeting Abstract
| Authors: | Hill, E.; Korde, N.; Morrison, C.; Dew, A.; Carpenter, A.; Epstein, M.; Lu, C.; Choyke, P.; Mena, E.; Lindenberg, L.; Landgren, O.; Kazandjian, D. |
| Abstract Title: | The role of (18)F-FDG-PET/CT in characterizing depth of response in high risk smoldering multiple myeloma patients treated with carfilzomib, lenalidomide, and dexamethasone (KRd) |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607547201248 |
| DOI: | 10.1182/blood-2020-136182 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
